Failure of Omalizumab treatment after recurrent systemic reactions to bee-venom immunotherapy

被引：0
|
作者：
Gomis, V. Soriano [1 ]
Delgado, P. Gonzalez [1 ]
Hernandez, E. Niveiro [1 ]
机构：
[1] Gen Hosp Univ Alicante, Secc Alergia, Alicante 0310, Spain
来源：
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY | 2008年 / 18卷 / 03期
关键词：
immunotherapy; omalizumab; anaphylactic reaction; bee venom;
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：225 / 226
页数：2
相关论文
共 50 条
  • [41] EFFICACY OF CONCURRENT TREATMENT WITH OMALIZUMAB IN A PATIENT WITH ANAPHYLAXIS TO VENOM IMMUNOTHERAPY
    Alnabulsi, R.
    Pak, Y.
    Pasha, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S107 - S107
  • [42] Systemic mastocytosis after anaphylactic reactions to hymenoptera venom immunotherapy: two cases
    Demirturk, M.
    Isik, S. R.
    Ozkan, G.
    Yavuz, A. S.
    ALLERGY, 2016, 71 : 437 - 438
  • [43] Anaphylactic Reactions During Bee Venom Immunotherapy in the Paediatric Population
    Wong, Jessica W. S.
    Courtney, Ashling
    O'Gorman, Tess
    Mckinnon, Elizabeth
    Noble, Valerie
    Itotoh, Benedicta
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2025, 61 (03) : 404 - 410
  • [44] Level of osteopontin is increased after bee venom immunotherapy
    Konno, S
    Golden, DBK
    Schroeder, J
    Hamilton, RG
    Lichtenstein, LM
    Huang, SK
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 115 (06) : 1317 - 1318
  • [45] OMALIZUMAB USE IN THE PREVENTION OF DELAYED REACTIONS POST VENOM IMMUNOTHERAPY: TWO CASES
    Moghaddas, Fiona
    Zubrinich, Celia
    Puy, Robert
    Douglass, Jo
    Weber, Eddie
    Wiedemann, Robert
    O'Hehir, Robyn
    INTERNAL MEDICINE JOURNAL, 2013, 43 : 12 - 12
  • [46] Risk factors for systemic reactions to bee venom in British beekeepers
    Richter, Alex G.
    Nightingale, Peter
    Huissoon, Aarnoud P.
    Krishna, Mamidipudi T.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 106 (02) : 159 - 163
  • [47] Omalizumab as adjuvant treatment during venom immunotherapy in mast cell disorders
    Vazquez-Revuelta, P.
    Gonzalez-De-Olano, D.
    Padial-Vilchez, A.
    Nunez-Acevedo, B.
    Frutos-Reche, M.
    ALLERGY, 2017, 72 : 684 - 685
  • [48] Formulation, characterization and cellular toxicity assessment of a novel bee-venom microsphere in prostate cancer treatment
    El-Didamony, Samia E.
    Amer, Reham, I
    El-Osaily, Ghada H.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [49] Severe anaphylaxis to hymenoptera venom immunotherapy: efficacy of pretreatment treatment with omalizumab
    Abou Taam, R.
    Ponvert, C.
    Rufin, P.
    Scheinmann, P.
    de Blic, J.
    ALLERGY, 2012, 67 : 404 - 405
  • [50] The incidence of systemic reactions to stings after venom immunotherapy: a case-control study
    Whisken, J.
    Deighton, J.
    Nasser, S.
    Parker, R.
    Wagner, A.
    Ewan, P.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2015, 45 (02): : 504 - 505
12345